Seegnal Inc. Announces Completion of Qualifying Transaction

CALGARY, ALBERTA – August 29, 2025 – Seegnal Inc. (formerly, Reem Capital Corp., a capital pool company, “Seegnal” or the “Corporation”) is pleased to announce that it has successfully completed its previously announced “Qualifying Transaction” pursuant to TSX Venture Exchange (“TSXV”) Policy 2.4 – Capital Pool Companies (the “Qualifying Transaction”). The Qualifying Transaction was completed pursuant to an amended and restated definitive securities exchange agreement dated January 27, 2025 (the “Definitive Agreement”) between the Corporation, Kalron Holdings Ltd. (“Kalron”), Seegnal eHealth Ltd. and certain securityholders of Kalron.

Trading in the common shares of Seegnal (“Seegnal Shares”) was previously halted at the request of Seegnal in connection with the initial announcement of the Qualifying Transaction and is expected to resume under the new ticker symbol “SEGN” on the TSXV in two business days following the date of issuance of the bulletin by the TSXV evidencing final acceptance of the Qualifying Transaction. The new CUSIP number is 81573E106 and the new ISIN is CA81573E1060 for the Seegnal Shares.

“This is a proud moment for Seegnal and everyone who has been part of our journey. Becoming a publicly traded company strengthens our ability to innovate, scale, and deliver on our mission to make medication management safer and smarter for patients and providers around the globe” said Eyal Schneid, CEO of Seegnal.